QUBIS Innovation Fund

QUBIS Innovation Fund is the commercialization and investment vehicle of Queen’s University Belfast, anchoring Northern Ireland’s deep science ecosystem with a particular concentration in medical devices and biotechnology. The fund is structured to translate university research into venture-backable companies, drawing on the academic output of Queen’s faculty, postdocs, and student founders. Its remit is firmly research-led, focused on hard science spinouts rather than software platforms, and it operates without a stated AI-specific mandate. Limited public information is available about the current QUBIS investment partners.

QUBIS invests at the Pre-Seed and Seed stages, deploying checks in the $250k to $1M range that are typically calibrated to support early company formation, IP licensing, and the first program of laboratory or clinical work. Geographic focus is concentrated on Northern Ireland, particularly Belfast, with portfolio companies generally either spun out of Queen’s directly or built in close proximity to the university. The fund frequently syndicates with Invest NI, Catalyst Inc, and other UK and Irish life sciences investors when rounds extend beyond its initial check capacity.

For academic founders, QUBIS provides a structured route from research to incorporation, including IP support, founding team formation, and access to the broader Queen’s research infrastructure. Spinout founders should expect close engagement with the university’s tech transfer process and the realities of academic equity arrangements. Pure software founders or those without a substantive deep science basis are unlikely to find QUBIS the right partner. For Northern Irish researchers commercializing medical device or therapeutic IP, however, QUBIS offers a credible local foundation investor with practical experience in the spinout journey.